drugset / Trial / NCT01339884
A Study of Resveratrol as Treatment for Friedreich Ataxia
Phase 1/2
Completed
27 enrolled
Murdoch Childrens Research Institute
Friedreich's Ataxia Research Alliance · collab
Non-randomizedParallel-groupOpen-labelTreatment
Summary
The purpose of this study is to determine the effect of two doses of resveratrol taken for a 12 week period, on frataxin levels in individuals with Friedreich ataxia. This study will also measure the effect of resveratrol on markers of oxidative stress, clinical measures of ataxia, and cardiac parameters.
Timeline
- Start
- 2011-04
- Primary completion
- 2012-08
- Completion
- 2012-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Resveratrol | Small molecule | 500 mg | — |
| Comparator | Resveratrol | Small molecule | 2.5 g | — |